Challenge for pharma firms: Funding for HIV research

Challenge for pharma firms: Funding for HIV research

According to numbers circulated by UNAIDS and the World Health Organization in November, the worldwide population of individuals living with HIV/AIDS in 2010 stood at 34 million. Yet despite the continuing importance of developing HIV vaccines, a range of research groups and small biopharma companies are finding challenges in obtaining the amount of funding that…